SF3B1 and B-cell chronic lymphocytic leukemia: Recurrent SF3B1 mutations have been reported in various cancer types, including chronic lymphocytic leukemia (CLL), and shown to induce altered splicing by alternative branch point usage or cryptic 3′ splice site selection [2–4].